More SEC Filings
View Older Stories View Newer Stories-
Form 497 FIRST TRUST EXCHANGE-TRA
-
Form 497K FIRST TRUST EXCHANGE-TRA
-
Form 497K FIRST TRUST EXCHANGE-TRA
-
Form D SU-0303 Fund I, a series
-
Form 8-K CORE MOLDING TECHNOLOGIE For: Mar 11
-
Form 8-K Vaxart, Inc. For: Mar 11
-
Form D AL-0512 Fund II, a serie
-
Form 8-K INTRUSION INC For: Mar 11
-
Form 8-K Astria Therapeutics, For: Mar 11
-
Form 8-K GMS Inc. For: Mar 11
-
Form 8-K Sagimet Biosciences Inc. For: Mar 11
-
Form 8-K Soluna Holdings, Inc For: Mar 11
-
Form 8-K Aspira Women's Health For: Mar 05
-
Form 8-K MADRIGAL PHARMACEUTICALS For: Mar 09
-
Form 10-K FULL HOUSE RESORTS INC For: Dec 31
-
Form ARS Archrock, Inc. For: Dec 31
-
Form 10-K Wheels Up Experience For: Dec 31
-
Form 4 Delek US Holdings, Inc. For: Mar 10 Filed by: Soreq Avigal
-
Form DEFA14A Archrock, Inc.
-
Form 8-K Douglas Elliman Inc. For: Mar 11
-
Form DEF 14A Archrock, Inc. For: Apr 24
-
Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Mar 10
-
Form 8-K Anika Therapeutics, Inc. For: Mar 07
-
Form 8-K PMGC Holdings Inc. For: Mar 07
-
Form 8-K ADVENT TECHNOLOGIES HOLD For: Mar 11
-
Form 8-K 1606 CORP. For: Mar 11
-
Form 8-K EXAGEN INC. For: Mar 11
-
Form 6-K SolarBank Corp For: Mar 11
-
Form 6-K AKANDA CORP. For: Mar 10
-
Form 8-K GLOBAL ACQUISITIONS Corp For: Mar 06
-
Form 6-K SILICOM LTD. For: Mar 11
-
Form DEFA14A Sabre Corp
-
Form S-8 Bioventus Inc.
-
Form S-8 Rapport Therapeutics,
-
Form DEFA14A OptimizeRx Corp
-
Form 425 SHYFT GROUP, INC. Filed by: Aebi Schmidt Holding AG
-
Form 40-F ENDEAVOUR SILVER CORP For: Dec 31
-
Form 10-K Bioventus Inc. For: Dec 31
-
Form C Sirocco Energy Inc.
-
Form 10-Q FUELCELL ENERGY INC For: Jan 31
-
Form 8-K Bioventus Inc. For: Mar 11
-
Form 6-K Hesai Group For: Mar 11
-
Form 8-K Xilio Therapeutics, Inc. For: Mar 11
-
Form 8-K Bath & Body Works, Inc. For: Mar 11
-
Form 10-K ACHIEVE LIFE SCIENCES, For: Dec 31
-
Form 8-K FUELCELL ENERGY INC For: Mar 11
-
Form 8-K ACHIEVE LIFE SCIENCES, For: Mar 11
-
Form 8-K AGENUS INC For: Mar 11
-
Form 8-K Holley Inc. For: Mar 11
-
Form 424B5 Werewolf Therapeutics,

